Jakarta International Hotels Development Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jakarta International Hotels Development Tbk trades at Rp430 (market cap 987.51B, 401.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Jakarta International Hotels Development Tbk is far larger — about 5.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Jakarta International Hotels Development Tbk is more actively traded (401.3K versus 96.7K). Which is the better fit depends on your goals.
| JIHD | OBAT | |
|---|---|---|
Market Cap | 987.51B | 167.37B |
Volume | 401.3K | 96.7K |
Lot | 4.01K | 967 |
Turnover | 173.08M | 23.82M |
Average Price | 431.29 | 246.34 |
Value | 173.08M | 23.82M |
Indicative Equilibrium Price | 430 | 248 |
Indicative Equilibrium Volume | 25 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.
Read more on JIHD →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →